Camil Sayegh

Camil Sayegh is a Chief Scientific Officer with a wealth of experience in leading research and development efforts in various pharmaceutical companies. With a background in immunology and biology, Camil has held key roles in companies such as Psivant Therapeutics, UCB, and Vertex Pharmaceuticals. Camil's expertise lies in developing novel therapeutics for a range of diseases, with a particular focus on kidney diseases and inflammatory conditions. Camil also has experience in co-founding a pharmaceutical company and overseeing research efforts in HIV therapeutics during their time at Merck.